Drug intelligence / Profile preview

DermaSIL

Development stage: Unknown
Lead developer: Chesebrough Pond's
Administration: Topical

Overview

**DermaSIL** is a non-specific rendering of the **Dermasil** product brand rather than one uniquely identifiable drug entity. Public OTC labels document materially different Dermasil products, including a topical **dimethicone 1%** skin-protectant lotion for dry, chapped, or cracked skin and a topical **alcohol 70%** antiseptic hand sanitizer. Because these products have different active ingredients and intended uses, the queried name cannot be assigned a single canonical active substance or unified mechanism of action. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8a49f4be-8a73-41ca-86f4-11a707b2987a))

Brand names: Dermasil

Beyond the preview

Go deeper on DermaSIL.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DermaSIL.

Explore the full profile